These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 15164602

  • 1. [Urine diacetylspermine as a novel tumor marker for pancreatobiliary carcinomas].
    Yamaguchi K, Nagano M, Torada N, Hamasaki N, Kawakita M, Tanaka M.
    Rinsho Byori; 2004 Apr; 52(4):336-9. PubMed ID: 15164602
    [Abstract] [Full Text] [Related]

  • 2. Urine diacetylspermine as a novel tumour maker for pancreatobiliary carcinomas.
    Yamaguchi K, Nakamura M, Shirahane K, Konomi H, Torata N, Hamasaki N, Kawakita M, Tanaka M.
    Dig Liver Dis; 2005 Mar; 37(3):190-4. PubMed ID: 15888284
    [Abstract] [Full Text] [Related]

  • 3. [Urine diacetylspermine as a novel tumor marker].
    Yamaguchi K, Kaku T, Enjoji M, Kato M, Anai M, Kawakita M, Hamasaki N, Tanaka M.
    Rinsho Byori; 2005 Feb; 53(2):130-5. PubMed ID: 15796046
    [Abstract] [Full Text] [Related]

  • 4. N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers.
    Hiramatsu K, Takahashi K, Yamaguchi T, Matsumoto H, Miyamoto H, Tanaka S, Tanaka C, Tamamori Y, Imajo M, Kawaguchi M, Toi M, Mori T, Kawakita M.
    Clin Cancer Res; 2005 Apr 15; 11(8):2986-90. PubMed ID: 15837752
    [Abstract] [Full Text] [Related]

  • 5. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P.
    Eur J Surg Oncol; 2005 Mar 15; 31(2):164-9. PubMed ID: 15698733
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Tumor markers for pancreatic and biliary tract cancer].
    Takezako Y, Okusaka T, Ueno H, Ikeda M, Morizane C, Najima M.
    Gan To Kagaku Ryoho; 2004 Sep 15; 31(9):1443-6. PubMed ID: 15446574
    [Abstract] [Full Text] [Related]

  • 8. [Clinical usefulness of urinary diacetylpolyamines as novel tumor markers].
    Kawakita M, Hiramatsu K, Sugimoto M, Takahashi K, Toi M.
    Rinsho Byori; 2004 Apr 15; 52(4):321-7. PubMed ID: 15164599
    [Abstract] [Full Text] [Related]

  • 9. Evaluating the utility of N1,N12-diacetylspermine and N1,N8-diacetylspermidine in urine as tumor markers for breast and colorectal cancers.
    Umemori Y, Ohe Y, Kuribayashi K, Tsuji N, Nishidate T, Kameshima H, Hirata K, Watanabe N.
    Clin Chim Acta; 2010 Dec 14; 411(23-24):1894-9. PubMed ID: 20655890
    [Abstract] [Full Text] [Related]

  • 10. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer.
    Jiang XT, Tao HQ, Zou SC.
    Hepatobiliary Pancreat Dis Int; 2004 Aug 14; 3(3):464-8. PubMed ID: 15313690
    [Abstract] [Full Text] [Related]

  • 11. [Establishment of an ELISA system of N1,N12-diacetylspermine in human urine].
    Matsuoka A, Sakamoto T.
    Rinsho Byori; 2004 Apr 14; 52(4):328-31. PubMed ID: 15164600
    [Abstract] [Full Text] [Related]

  • 12. Diacetylated derivatives of spermine and spermidine as novel promising tumor markers.
    Kawakita M, Hiramatsu K.
    J Biochem; 2006 Mar 14; 139(3):315-22. PubMed ID: 16567395
    [Abstract] [Full Text] [Related]

  • 13. [Role of the tumor markers CA 19-9 and carcinoembryonic antigen (CEA) in diagnosis, treatment and prognosis of pancreatic cancer].
    Kokhanenko NIu, Ignashov AM, Varga EV, Polkanova MS, Aleshina LA, Kimbarovskaia AA, Osipenko SK, Lebedev EG.
    Vopr Onkol; 2001 Mar 14; 47(3):294-7. PubMed ID: 11544826
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identifying markers for pancreatic cancer by gene expression analysis.
    Zhou W, Sokoll LJ, Bruzek DJ, Zhang L, Velculescu VE, Goldin SB, Hruban RH, Kern SE, Hamilton SR, Chan DW, Vogelstein B, Kinzler KW.
    Cancer Epidemiol Biomarkers Prev; 1998 Feb 14; 7(2):109-12. PubMed ID: 9488584
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.
    Kim HJ, Kim MH, Myung SJ, Lim BC, Park ET, Yoo KS, Seo DW, Lee SK, Min YI.
    Am J Gastroenterol; 1999 Jul 14; 94(7):1941-6. PubMed ID: 10406263
    [Abstract] [Full Text] [Related]

  • 19. [Urinary diacetylspermine: its analysis and performance as a novel tumor marker].
    Kawakita M, Hiramatsu K, Takahashi K, Yamada R, Kawaguchi M, Shinoura N, Tanaka T, Kariyone K, Tamamori Y, Sasaki Y, Mori T.
    Rinsho Byori; 2005 Feb 14; 53(2):123-9. PubMed ID: 15796045
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X, Lu XH, Xu T, Qian JM, Zhao P, Guo XZ, Yang XO, Jiang WJ.
    Chin J Dig Dis; 2006 Feb 14; 7(3):170-4. PubMed ID: 16808798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.